Issued Patents 2018
Showing 1–8 of 8 patents
| Patent # | Title | Co-Inventors | Date |
|---|---|---|---|
| 10130628 | Treatment of joint pain | Nathaniel David, Albert Davalos, Remi-Martin Laberge, Marco Demaria, Alain P. Vasserot +6 more | 2018-11-20 |
| 10010546 | Treatment of ophthalmic conditions by selectively removing senescent cells from the eye | Remi-Martin Laberge, Marco Demaria, Nathaniel David, Alain P. Vasserot, James L. Kirkland +5 more | 2018-07-03 |
| 9993472 | Treatment for osteoarthritis in a joint by administering a means for inhibiting MDM2 | Remi-Martin Laberge, Albert Davalos, Marco Demaria, Nathaniel David, Alain P. Vasserot +7 more | 2018-06-12 |
| 9980962 | Use of sulfonamide inhibitors of Bcl-2 to treat senescence-associated lung conditions such as pulmonary fibrosis and chronic obstructive pulmonary disease | Remi-Martin Laberge, Marco Demaria, Nathaniel David, Darren J. Baker, James L. Kirkland +3 more | 2018-05-29 |
| 9901081 | Transgenic mouse for determining the role of senescent cells in cancer | Marco Demaria, Francis Rodier, Remi-Martin Laberge, James B. Mitchell, Jan H. J. Hoeijmakers +1 more | 2018-02-27 |
| 9901080 | Transgenic mouse having a transgene that converts a prodrug into a cytotoxic compound in senescent cells | Marco Demaria, Remi-Martin Laberge, Francis Rodier, James B. Mitchell, Jan H. J. Hoeijmakers +1 more | 2018-02-27 |
| 9884065 | Inhibiting activity of senescent cells using a glucocorticoid | Remi-Martin Laberge, Francis Rodier, Marco Demaria | 2018-02-06 |
| 9855266 | Treatment for osteoarthritis by intra-articular administration of a cis-imidazoline | Remi-Martin Laberge, Albert Davalos, Marco Demaria, Nathaniel David, Alain P. Vasserot +6 more | 2018-01-02 |